CD274 and non-small cell lung carcinoma: Xin Zhou et al. (2022) evaluated for the first time in humans the biodistribution, metabolism, radiation dosimetry, safety, and potential of [68Ga]Ga-NOTA-WL12 as a PET probe in quantifying programmed death ligand-1 (PD-L1) expression levels in patients with advanced NSCLC.